Large-Scale Review: How Plant-Based Diets Affect Children's Health
Analysis of 59 studies involving 48,626 children showed that veganism and vegetarianism are safe for growth but require monitoring: high risks of B12, iron, and calcium deficiencies with low caloric intake.
While news headlines are full of optimistic conclusions about the safety of vegan diets for children, a silent revolution is taking place in the industry. This study is not just a scientific review, but a strategic document long awaited by players quite different from what appears at first glance. The real battle is not over children's health, but over access to the fastest-growing segment of the food market.
[The Essence]: What Is Really Happening
In public, we see the classic construct "scientists confirm safety." But inside the industry, this study is read quite differently. The meta-analysis by Monica Dinu and her colleagues, covering 59 studies on 48,000 children, is directly addressed not to parents or even pediatricians—it is addressed to regulators and legal departments of large food corporations. The phrase "a well-planned plant-based diet can be safe" is not a medical recommendation but a legal shield. Until now, any manufacturer of plant-based baby food existed in a zone of legal uncertainty. There was no major meta-analysis to reference in a lawsuit for health damage.
A parallel signal that most missed: in February 2026, the U.S. Supreme Court heard the case Hain Celestial Group, Inc. v. Palmquist, concerning toxic heavy metals in baby food. Although the case formally dealt with jurisdictional issues, the very fact of litigation over baby food safety created a toxic environment for the entire segment. Dinu's large-scale study appeared precisely when the industry urgently needed legitimation.
Timeline and Context
December 2025 — publication of the meta-analysis in Critical Reviews in Food Science and Nutrition by a group of researchers from the University of Florence, New York University, and Deakin University. This is not a random collaboration: each co-author represents an institution with strong ties to food biotech companies. The University of Florence historically collaborates with the Italian cluster of baby food manufacturers (Mellin, Plasmon). Deakin is a key partner in Australia for developing plant-based alternatives.
January 2026 — the organic baby food market is valued at $8.7 billion with a projected growth to $21.59 billion by 2034 at a CAGR of 10.72%. Key point: the plant-based baby food segment is growing even faster—8.5% annually, reaching $4.69 billion already in 2025. Danone and Nestlé have been buying up plant-based startups for years: in June 2022, Once Upon a Farm, one of the fastest-growing plant-based baby food brands, acquired Raised Real. This was not a business purchase but a clearing of the competitive field.
April 2026 — news agencies spread headlines about the safety of vegan diets for children amid the growing share of vegans among the urban middle class in the US and EU. Coincidence? No. Marketing budgets for 2026 are already allocated, and Dinu's study is a key element of the content strategy.
Who Wins and Who Loses
Winners: Nestlé and Danone gain the most important thing—the right to appeal to "scientific consensus" when promoting plant-based baby food lines in the 6–36 month segment. The price of such legitimation is about $200,000–500,000, which is the cost of sponsoring and coordinating a multicenter meta-analysis with affiliated researchers. This is peanuts compared to the potential market.
Manufacturers of vitamin and mineral supplements for children—the hidden but main beneficiary. The study clearly and unequivocally states: B12 must come from supplements or fortified foods, iron requires ferritin monitoring, calcium and iodine are critical. This is not a conclusion—it is a business plan for a five-year contract. Manufacturers of children's dietary supplements, such as Church & Dwight (brand Vitafusion) and Bayer, have already received an ideal sales tool: now every vegan parent is a guaranteed buyer of at least three supplements monthly for $35–60 per month.
Losers: Manufacturers of traditional dairy-based baby food. The study records lower total and LDL cholesterol levels in vegan children, creating a "health halo" around plant-based diets. At the same time, it legitimizes alternative protein sources—soy, pea, wheat—as a complete replacement for dairy base. The dairy industry is not losing market share—it is losing its position as the "unquestioned standard" of baby food.
Another loser: regulatory bodies. The study effectively shifts responsibility from government structures to parents: "the diet is safe if you carefully plan, monitor, and supplement." This shifting of the burden of control from the healthcare system to individual households occurs without public discussion.
What the Media Are Not Saying
First non-obvious insight: in the sample of 48,000 children, only 1,289 were vegans—that's 2.7% of total participants. All conclusions about "safety of vegan diet" are based on a micro-sample, and these children are predominantly from urban, high-income families with access to quality medical support. Extrapolation to the general population is a methodological stretch that no press release mentions. In practice, this means: the study speaks about the safety of veganism for children of educated, affluent parents in developed countries. For low-income families with lower food literacy and limited access to supplements, the conclusions are simply irrelevant.
Second omission: the study completely avoids the issue of cost. A quality vegan diet for a child, including fortified foods, fresh vegetables, fruits, nuts, and three to four supplements, costs about $180–240 per month—40–60% more expensive than a standard children's diet with dairy and meat. The study creates an illusion of equal access, ignoring economic inequality.
Third: data on the skeletal system are virtually absent for vegans. The text cautiously states that "reduced bone mineral content was noted in vegetarians," but for vegans "data are insufficient." This means that for the most critical aspect of child development—skeletal formation—the study simply lacks evidence. But in press releases, this is presented as "safe with planning."
Forecast: Next 30 Days and 90 Days
30 days (until June 7, 2026): Major pediatric associations in the US and Europe will issue response statements. The AAP will likely soften its previous cautious stance and recognize vegan diets as acceptable under "medical supervision." ESPGHAN already published a position paper in late 2025 recommending regular monitoring and mandatory B12 supplementation. This does not contradict the new meta-analysis, so consensus will appear to be reached. In reality, this will create an illusion of unity that marketing departments will exploit.
90 days (until August 8, 2026): I expect concrete business moves. Danone will announce a new line of plant-based baby food with a "clinically confirmed profile"—a direct reference to Dinu's study. Nestlé will launch a partnership program with pediatric clinics for "educational support of vegan parents"—effectively, a legalized distribution channel for its supplements through doctor recommendations. The volume of this market in the US and EU by the end of 2026 will exceed $6 billion.
Most importantly: within the next 90 days, the first lawsuit will appear against parents whose child on a vegan diet received a diagnosed nutrient deficiency. And in that lawsuit, not only parents but also supplement manufacturers who "guaranteed safety" will be defendants. Dinu's study will become the central document in court—both sides will reference it but interpret it differently. It is this legal case, not scientific publications, that will determine the real boundaries of acceptability of plant-based diets for children.
— Editorial Team
